ROOT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient trader. ROOT is in a clear short-term downtrend (bearish MA stack and worsening MACD), and while it’s deeply oversold (RSI14) and could bounce, there’s no Intellectia buy signal and price is sitting just above key support (59.59–62.46). Without confirmation of a reversal, the higher-probability trade is to avoid/hold rather than buy into a falling trend.
Trend is bearish. Moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), indicating sustained downside momentum. MACD histogram is -0.837 and negatively expanding, confirming that bearish momentum is strengthening rather than fading. RSI_6 at ~13.9 signals extreme oversold conditions, which often precede short-term bounces, but oversold alone is not a buy trigger when momentum is still deteriorating. Key levels: Pivot ~67.09 (well above current price 60.23, indicating price is below the balance area). Immediate supports: S1 ~62.46 (already below it) and S2 ~59.59 (nearby). A break below ~59.6 would open further downside; any rebound faces resistance first near ~67.1 then ~71.7.
Extreme oversold RSI (~
can fuel a sharp short-term mean-reversion bounce if selling pressure eases.
Options sentiment skewed bullish (low put-call ratios), implying traders are positioned for upside.
Pattern-based projection suggests upside odds: ~60% chance of +1.31% next day, +5.55% next week, +11.56% next month (model-based, not a confirmation signal).
Next earnings: QDEC 2025 on 2026-02-25 (Est. EPS 0.
could become a catalyst if results/guide surprise positively.
Downtrend is intact and strengthening (bearish MA stack + MACD histogram expanding negatively).
Price is below the pivot (~67.
and hovering near key support (~59.59–62.46); a support break can accelerate selling.
No recent news catalyst to interrupt momentum (no news in the last week).
No hedge fund/insider accumulation signals (both neutral), so there’s no clear “smart money” tailwind visible.
Earnings risk ahead (2026-02-
can keep buyers cautious if fundamentals haven’t clearly turned.
Latest quarter (2025/Q3): Revenue rose to 387.8M (+26.86% YoY), showing strong top-line growth. However profitability deteriorated: Net income fell to -5.4M (down -124.88% YoY) and EPS to -0.35 (down -127.34% YoY). The setup is growth improving but earnings power weakening in the most recent quarter—this mismatch can pressure the stock during risk-off tape and helps explain the current bearish technicals.
Recent analyst action: (2025-11-07) Keefe Bruyette lowered price target to $150 from $165 but maintained an Outperform rating. Wall Street pro view (from the limited data provided): Pro—still sees meaningful upside versus current price and keeps a bullish rating. Con—cutting the target is a negative revision and suggests expectations have moderated. Overall: analyst stance is positive, but the direction of change (lower PT) is not supportive near-term.
